A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohns Disease Who Have Been Previously Treated With Anti-TNF Therapy

This study has been completed.

Study NCT00771667 Information provided by Centocor, Inc.

First Received: October 10, 2008 Last Updated: April 26, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2010
Primary Completion Date:	May 2010 (Final data collection date for primary outcome measure)
Extension Request:	Submission Date: April 26, 2011 Status: Submitted